Matches in Wikidata for { <http://www.wikidata.org/entity/Q64173148> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q64173148 description "clinical trial" @default.
- Q64173148 description "ensayu clínicu" @default.
- Q64173148 description "klinisch onderzoek" @default.
- Q64173148 description "клінічне випробування" @default.
- Q64173148 name "Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients" @default.
- Q64173148 type Item @default.
- Q64173148 label "Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients" @default.
- Q64173148 prefLabel "Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients" @default.
- Q64173148 P1132 Q64173148-1931CF88-0F43-44A9-BEF4-6C0D36B666E0 @default.
- Q64173148 P1476 Q64173148-F8909E3C-B7B5-40BE-B790-483921C54218 @default.
- Q64173148 P17 Q64173148-C7381953-B183-4664-8656-BC36B482E8E4 @default.
- Q64173148 P1813 Q64173148-101C9C2D-5AC4-4893-961D-6613340D10D6 @default.
- Q64173148 P2899 Q64173148-AB33BB5A-02DE-47A1-B5F6-12DEBDA77F3F @default.
- Q64173148 P3098 Q64173148-CF404956-2AF5-4D3E-9F51-5D0548B6C772 @default.
- Q64173148 P31 Q64173148-5A165A96-5116-4A6F-81EC-842E12754BFD @default.
- Q64173148 P4844 Q64173148-0DF04D3D-68CB-4492-8BED-978E4E74C680 @default.
- Q64173148 P4844 Q64173148-18FB55B7-E46A-460B-8970-0BA870B972CB @default.
- Q64173148 P4844 Q64173148-3670D8EA-BCE4-4875-8AC0-FD8859E95969 @default.
- Q64173148 P4844 Q64173148-44D6CF69-AD83-4C0E-9E77-F57F025BF2D2 @default.
- Q64173148 P4844 Q64173148-D3E41D82-1577-45A3-9031-CB7773FD6D85 @default.
- Q64173148 P580 Q64173148-7400DB63-3608-4E2D-96F6-1D08AE1CCBE8 @default.
- Q64173148 P582 Q64173148-BB924B93-BCC8-4324-8D92-A567E1AD26E6 @default.
- Q64173148 P6099 Q64173148-1FA4754D-2D72-4740-85AB-9A659CE82BE7 @default.
- Q64173148 P8363 Q64173148-AB3924DA-7840-4B5C-BEF7-F975770DE45C @default.
- Q64173148 P1132 "+257" @default.
- Q64173148 P1476 "A Prospective, Randomized, Multicenter, Open-label Comparison of Pre-surgical Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy Given for Twelve Weeks With a Quality of Life Assessment of Trastuzumab, Pertuzumab in Combination With Standard (Neo)Adjuvant Treatment in Patients With Operable HER2+/HR+ Breast Cancer." @default.
- Q64173148 P17 Q183 @default.
- Q64173148 P1813 "TP-II" @default.
- Q64173148 P2899 "+18" @default.
- Q64173148 P3098 "NCT03272477" @default.
- Q64173148 P31 Q30612 @default.
- Q64173148 P4844 Q1998021 @default.
- Q64173148 P4844 Q408524 @default.
- Q64173148 P4844 Q412178 @default.
- Q64173148 P4844 Q423762 @default.
- Q64173148 P4844 Q907160 @default.
- Q64173148 P580 "2017-10-05T00:00:00Z" @default.
- Q64173148 P582 "2020-03-15T00:00:00Z" @default.
- Q64173148 P6099 Q42824440 @default.
- Q64173148 P8363 Q78089383 @default.